The fermentation and isolation of 1 were carried out in the same wayas reported previously1}. Astock culture of the producing organism was inoculated into a test tube (i.d. 2x20cm) containing 10ml of seed medium consisting of2% glucose, 0.5% peptone, 0.3% dry yeast, 0.5% meat extract, 0.5% NaCl and 0.3% CaCO3 (pH 7.0 before sterilization).
The tube was incubated at 27°C for 72 hours on a reciprocal shaker. Then, 2ml portions of the culture were transferred to a 500-ml Erlenmeyer flask containing 100ml of the seed medium. The flask was incubated at 27°C for 48 hours on a rotary shaker (210rpm), and 400ml of the resulting culture was transferred into a 50-liter fermenter containing 30 liters of the same mediumas described above. The fermentation was carried out at 27°C for 96 hours of an agitation rate of 160rpmand an aeration rate of 60 liters per minute.
The fermentation broth of Streptomyces sp. OH-3984 (30 liters) was extracted with EtOAc (25 liters), and the EtOAc layer was dried over anhydrous Na2SO4 and Furthermore, the 13C and XH NMRchemical shifts between C-l and C-5 were similar to those of 2,3-dihydroalbocycline2). However, the signal of the methoxy group, a characteristic functional group of albocycline, was not observed. In the 1H-1H COSYspectrum of 1, the connection from C-5 to C-13 via a long range coupling between H-7 (3 6.09) and H-9 (3 3.70) was demonstrated.
Final confirmation of structure 1 was undertaken using HMBCexperiments (/=8 Hz) summarized in Table 2 .
These results clearly indicated that the structure is the derivative of albocycline without a methoxy group as shown in the Fig. 1 . Although this structure is similar to that of cineromycin B5), a 14-membered macrocyclic compoundwithout a methoxy group, the physicochemical and biological properties of 1 are different from those of cineromycin B. Cineromycin B was reported as a C-1. C-3. C-4 C-l, C-2, C-4, 4-Me, C-5 C-3, C-4, 4-Me, C-6, C-7 C-4, C-5, C-7, C-8 C-5, C-6, C-8, 8-Me, C-9 C-8, 8-Me, C-10, C-ll C-8, C-9, C-ll, C-12 C-9, C-10, C-12, 12-Me, C-13 C-ll, 12-Me, C-13, 13-Me C-1. C-ll.
C-12. 12-Me, 13-Me C-3, C-4, C-5 C-7, C-8, C-9 C-ll, C-12, C-13 C-12, C-13 antibacterial activity, however, the structure of cineromycin B was not clearly elucidated6). Albocycline K3 (1) inhibited the melanogenesis of B16 melanoma cells at a concentration of 15.0 /ig/ml without cytotoxicity using the previously described method1*. Albocycline K3 (1) showed no antimicrobial activity against Gram-positive and Gram-negative bacteria, fungi or yeast at a concentration of 1.0mg/ml in the paper disc method reported previously7). Recently, the search for new melanin biosynthesis inhibitors of microbial origin has been performed using some unique screening methods, and isonitrile antibiotics, trichoviridin8) and MR304A9)were reported to inhibit not only melanogenesis but also mushroomtyrosinase. However, the mechanismof action of 1 is unknownsince no inhibition of tyrosinase activity was observed by the method of Akiu et al.10) and Pomerantz et al.lx\ Therefore, it is of interest to examine the mechanism of the inhibitory effect of albocycline K3 (1) on melanogenesis.
